purpose determine radiobiologic parameters gliomas methods materials biologic effective dose concept used estimate ratio k dose equivalent tumor glioma patients treated randomized fractionation trial equivalent radiation dose temozolomide temodar chemotherapy estimated randomized study method assumes radiotherapy biologic effective dose proportional adjusted radiotherapy survival duration glioma patients results median tumor k estimate NUMBER gy NUMBER respectively using published surviving fraction exposure sf2 data ratio estimated median alpha value NUMBER beta NUMBER cellular doubling time NUMBER days median equivalent biologic effective dose temozolomide NUMBER gy93 equivalent radiation dose NUMBER gy given fractions random sampling trial simulations based cure threshold NUMBER gy gliomas shown potential increase tumor cure dose escalation partial elimination hypoxic cells chemical hypoxic cell sensitizers carbon ion therapy suggested considerable gains tumor control supplemented temozolomide achievable conclusion radiobiologic parameters human gliomas estimated clinical trials used inform future clinical trials particularly combined modality treatments newer forms radiotherapy incurable cancers studied using similar radiobiologic analysis high grade high grade high grade NUMBER gy gy NUMBER gy NUMBER NUMBER gy high grade high grade alpha beta repopulation d alpha beta gy d alpha beta